Invasive carcinoma of no special type

Invasive Carcinoma of No Special Type (IC-NST), also known as Invasive Ductal Carcinoma (IDC) of no special type, is the most common form of breast cancer. It is characterized by cancer cells that have spread beyond the ducts into the surrounding breast tissue. This article provides an overview of IC-NST, including its pathology, diagnosis, treatment, and prognosis.

Pathology

IC-NST originates in the milk ducts of the breast and invades the fibrous or fatty tissue of the breast outside the duct. It is termed "no special type" because it does not have the specific features that characterize other types of breast cancer, such as lobular carcinoma or inflammatory breast cancer. Under the microscope, IC-NST is characterized by a lack of specialized features, but it may exhibit a wide range of differentiation and aggressiveness.

Diagnosis

The diagnosis of IC-NST typically involves a combination of imaging tests and a biopsy. Mammography and ultrasound are commonly used to detect abnormalities in the breast tissue. If these imaging tests reveal a suspicious area, a biopsy is performed to collect cells from the tumor for microscopic examination. The biopsy not only confirms the presence of cancer but also determines its type and grade.

Treatment

Treatment for IC-NST depends on the stage of the disease, the size of the tumor, the patient's age and general health, and other factors. Treatment options may include:

• Surgery: This may involve a lumpectomy (removal of the tumor and a small margin of surrounding tissue) or mastectomy (removal of one or both breasts).
• Chemotherapy: The use of drugs to kill cancer cells, often used before surgery (neoadjuvant chemotherapy) to shrink the tumor or after surgery (adjuvant chemotherapy) to kill any remaining cancer cells.
• Radiation therapy: The use of high-energy rays to target and kill cancer cells, typically used after surgery to eliminate any remaining cancer cells in the breast.
• Hormone therapy: For tumors that are hormone receptor-positive, medications that block hormones can be used to slow or stop the growth of cancer cells.
• Targeted therapy: For tumors that have certain genetic markers, targeted therapy drugs can be used to specifically attack cancer cells without harming normal cells.

Prognosis

The prognosis for patients with IC-NST varies depending on several factors, including the stage of the cancer at diagnosis, the tumor grade, and the patient's overall health. Early detection and treatment are crucial for improving the prognosis. The 5-year survival rate for breast cancer, in general, has been improving over the years due to advances in treatment and awareness.

Prevention and Screening

While there is no sure way to prevent IC-NST, certain lifestyle changes can reduce the risk of developing breast cancer. These include maintaining a healthy weight, exercising regularly, limiting alcohol consumption, and avoiding tobacco use. Regular screening through mammography can also help detect breast cancer at an early stage, when it is most treatable.

‎ ‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian